Author

Qi Li

Observed name: Li, Qi

Institutions: National Institutes of Health, Harbin Medical University, Third Affiliated Hospital of Harbin Medical University, National Cancer Institute, Center for Cancer Research

Observed institutions: National Institutes of Health, Harbin Medical University, Third Affiliated Hospital of Harbin Medical University, National Cancer Institute, Center for Cancer Research

ORCID: 0009-0000-5823-799X

Observed ORCID: 0009-0000-5823-799X

OpenAlex ID: A5092363973

MicroRNA-375 restrains the progression of lung squamous cell carcinoma by modulating the ERK pathway via UBE3A-mediated DUSP1 degradation

2023 · Junqing Gan, Yu Zhang, et al. · Cell Death Discovery · 15

Targeting the Mitochondria in High-Grade Gliomas

2025 · Shaunak Sathe, Qi Li, et al. · Cancers · 10

MicroRNA-375 promotes tamoxifen resistance by stabilizing ERα via UBE3A-mediated ubiquitination

2026 · Dinglong Xue, Yuyan Xie, et al. · International Immunopharmacology · 1

Targeting Mitochondrial Protease in Diffuse Gliomas

2026 · Olga Kim, Jinkyu Jung, et al. · Molecular Cancer Therapeutics

Abstract 5672: PRMT5 inhibition enhances therapeutic vulnerability to Bcl-xL/Bcl-2 inhibitors in glioblastoma.

2026 · Shumpei Onishi, Ashis Chowdhury, et al. · Cancer Research

Asiaticoside enhances the antitumor efficacy of MSLN-targeted CAR-T cells in ovarian cancer

2026 · Wei Jiang, Juanwen Cao, et al. · Journal of Translational Medicine

Works count: 8

Citation count: 26

H-index: 2

I10-index: 2